Hasham S. Sofi

1.0k total citations
43 papers, 743 citations indexed

About

Hasham S. Sofi is a scholar working on Biomaterials, Infectious Diseases and Biomedical Engineering. According to data from OpenAlex, Hasham S. Sofi has authored 43 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Biomaterials, 12 papers in Infectious Diseases and 12 papers in Biomedical Engineering. Recurrent topics in Hasham S. Sofi's work include Electrospun Nanofibers in Biomedical Applications (23 papers), Graphene and Nanomaterials Applications (7 papers) and Tuberculosis Research and Epidemiology (6 papers). Hasham S. Sofi is often cited by papers focused on Electrospun Nanofibers in Biomedical Applications (23 papers), Graphene and Nanomaterials Applications (7 papers) and Tuberculosis Research and Epidemiology (6 papers). Hasham S. Sofi collaborates with scholars based in India, United States and Saudi Arabia. Hasham S. Sofi's co-authors include Faheem A. Sheikh, Mushtaq A. Beigh, Nadeem Shabir, Sašo Ivanovski, Yu Shrike Zhang, Ashif H. Tamboli, Shafquat Majeed, Rajesh Vasita, Arvind H. Jadhav and Rabia Hamid and has published in prestigious journals such as Chemical Engineering Journal, International Journal of Molecular Sciences and International Journal of Pharmaceutics.

In The Last Decade

Hasham S. Sofi

40 papers receiving 733 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hasham S. Sofi India 12 446 262 98 86 83 43 743
Merve Gültekinoğlu Türkiye 15 438 1.0× 278 1.1× 59 0.6× 81 0.9× 110 1.3× 34 823
Semih Çalamak Türkiye 16 524 1.2× 350 1.3× 115 1.2× 104 1.2× 167 2.0× 23 951
Prasanna Kumar India 3 483 1.1× 239 0.9× 58 0.6× 77 0.9× 52 0.6× 8 774
Serdar Tort Türkiye 14 441 1.0× 276 1.1× 141 1.4× 44 0.5× 132 1.6× 30 759
Sümeyye Cesur Türkiye 17 479 1.1× 361 1.4× 69 0.7× 49 0.6× 181 2.2× 35 837
Christiane Bertachini Lombello Brazil 15 320 0.7× 333 1.3× 74 0.8× 87 1.0× 55 0.7× 34 808
Shadab Bagheri‐Khoulenjani Iran 18 677 1.5× 507 1.9× 120 1.2× 136 1.6× 84 1.0× 39 1.1k
Muhammad Mustafa Abeer Australia 10 476 1.1× 280 1.1× 119 1.2× 151 1.8× 41 0.5× 12 866
Hamid Mahdavi Iran 15 327 0.7× 255 1.0× 220 2.2× 70 0.8× 70 0.8× 26 821
Nouf Alghamdi Saudi Arabia 7 286 0.6× 319 1.2× 77 0.8× 65 0.8× 50 0.6× 15 823

Countries citing papers authored by Hasham S. Sofi

Since Specialization
Citations

This map shows the geographic impact of Hasham S. Sofi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hasham S. Sofi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hasham S. Sofi more than expected).

Fields of papers citing papers by Hasham S. Sofi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hasham S. Sofi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hasham S. Sofi. The network helps show where Hasham S. Sofi may publish in the future.

Co-authorship network of co-authors of Hasham S. Sofi

This figure shows the co-authorship network connecting the top 25 collaborators of Hasham S. Sofi. A scholar is included among the top collaborators of Hasham S. Sofi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hasham S. Sofi. Hasham S. Sofi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khan, Rumysa Saleem, Taha Umair Wani, Anjum Hamid Rather, et al.. (2025). Janus Nanocomposite for Enhanced Bone Tissue Engineering: Polyurethane Nanofibers with Zoledronic Acid–Silk Fibroin and Silver‐Infused Chitosan Hydrogel. Advanced Engineering Materials. 27(9).
2.
Garg, Tanu, Hasham S. Sofi, Kavita Singh, et al.. (2025). Preclinical model of Mycobacteroides abscessus lung disease by nose-only exposure of mice to bacterial powder aerosol. Tuberculosis. 151. 102606–102606. 1 indexed citations
3.
4.
Gani, Adil, et al.. (2025). Formulation design of quercetin-loaded polyvinyl alcohol nanofibres for ocular drug delivery. Food Hydrocolloids for Health. 8. 100244–100244.
5.
Sofi, Hasham S., Anjum Hamid Rather, Rumysa Saleem Khan, et al.. (2025). Designing sustained release from nanofiber patch for paclitaxel as prospective localized nanotherapeutic delivery in breast cancer. International Journal of Pharmaceutics. 671. 125158–125158. 1 indexed citations
6.
Sofi, Hasham S., Sally E. Dickinson, Georg T. Wondrak, et al.. (2024). Comprehensive Advanced Physicochemical Characterization and In Vitro Human Cell Culture Assessment of BMS-202: A Novel Inhibitor of Programmed Cell Death Ligand. Pharmaceutics. 16(11). 1409–1409. 1 indexed citations
7.
8.
Sofi, Hasham S., Trisha Roy, Ghulam Nabi Bader, et al.. (2024). Optimizing the fabrication of electrospun nanofibers of prochlorperazine for enhanced dissolution and permeation properties. Biomaterials Advances. 158. 213773–213773. 4 indexed citations
9.
Sofi, Hasham S., Sonia Verma, Sanjay Singh, et al.. (2024). Macrophage-targeted versus free calcitriol as host-directed adjunct therapy against Mycobacterium tuberculosis infection in mice is bacteriostatic and mitigates tissue pathology. Tuberculosis. 148. 102536–102536. 3 indexed citations
10.
11.
Verma, Sonia, Hasham S. Sofi, Trisha Roy, et al.. (2023). Inhaled Adjunct Therapy with Second-Line Drug Candidates for Dose Reduction in Chemotherapeutic Regimens for Multi-drug-Resistant Tuberculosis. AAPS PharmSciTech. 24(5). 130–130. 7 indexed citations
12.
Verma, Sonia, Hasham S. Sofi, Lubna Azmi, et al.. (2022). Transient, inhaled gene therapy with gamma interferon mitigates pathology induced by host response in a mouse model of tuberculosis. Tuberculosis. 134. 102198–102198. 11 indexed citations
13.
Sofi, Hasham S., Hilal Rather, Nadeem Shabir, et al.. (2020). Fabrication of multifunctional cellulose/TiO2/Ag composite nanofibers scaffold with antibacterial and bioactivity properties for future tissue engineering applications. Journal of Biomedical Materials Research Part A. 108(4). 947–962. 33 indexed citations
14.
Sofi, Hasham S., Sonia Verma, Amit Kumar Singh, et al.. (2020). Transient Transfection of the Respiratory Epithelium with Gamma Interferon for Host-Directed Therapy in Pulmonary Tuberculosis. Molecular Therapy — Nucleic Acids. 22. 1121–1128. 9 indexed citations
15.
Sofi, Hasham S., et al.. (2020). Electrospun nanofibers for the delivery of active drugs through nasal, oral and vaginal mucosa: Current status and future perspectives. Materials Science and Engineering C. 111. 110756–110756. 96 indexed citations
16.
Sofi, Hasham S., et al.. (2019). Recent trends in peripheral nervous regeneration using 3D biomaterials. Tissue and Cell. 59. 70–81. 8 indexed citations
17.
Wani, Taha Umair, Hasham S. Sofi, Nisar Ahmad Khan, & Faheem A. Sheikh. (2019). Experimental Protocol for Induction of Transgene Expression in Neural Stem Cells Through Polymeric Nanoparticles. Methods in molecular biology. 2125. 77–84. 1 indexed citations
18.
Sofi, Hasham S., et al.. (2019). Experimental Protocol of MSC Differentiation into Neural Lineage for Nerve Tissue Regeneration Using Polymeric Scaffolds. Methods in molecular biology. 2125. 109–117. 4 indexed citations
19.
Sofi, Hasham S., et al.. (2018). Scaffolds Fabricated from Natural Polymers/Composites by Electrospinning for Bone Tissue Regeneration. Advances in experimental medicine and biology. 1078. 49–78. 33 indexed citations
20.
Sofi, Hasham S., Tabassum Khan, Rajeev Ranjan, et al.. (2017). Dehydroascorbate-derivatized chitosan particles for targeting antimalarial agents to infected erythrocytes. International Journal of Pharmaceutics. 524(1-2). 205–214. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Merve Gültekinoğlu Breakdown of academic impact, for papers by Semih Çalamak Breakdown of academic impact, for papers by Prasanna Kumar Breakdown of academic impact, for papers by Serdar Tort Breakdown of academic impact, for papers by Sümeyye Cesur Breakdown of academic impact, for papers by Christiane Bertachini Lombello Breakdown of academic impact, for papers by Shadab Bagheri‐Khoulenjani Breakdown of academic impact, for papers by Muhammad Mustafa Abeer Breakdown of academic impact, for papers by Hamid Mahdavi Breakdown of academic impact, for papers by Nouf Alghamdi
Rankless by CCL
2026